Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF – Get Free Report)’s share price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $10.72 and traded as high as $10.84. Ono Pharmaceutical shares last traded at $10.84, with a volume of 1,326 shares.
Ono Pharmaceutical Price Performance
The business’s 50 day moving average price is $10.72 and its 200-day moving average price is $12.87. The firm has a market capitalization of $5.57 billion, a price-to-earnings ratio of 8.09 and a beta of 0.56.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Recommended Stories
- Five stocks we like better than Ono Pharmaceutical
- What is the Dogs of the Dow Strategy? Overview and Examples
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Retail Stocks Investing, Explained
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Trading Stocks: RSI and Why it’s Useful
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
